Position in AGIO
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,482,073
+$463,629 QoQ
Shares Held
73,369
-1.1% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,289,073 across 287 Biotechnology names. AGIO ranks #73 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in AGIO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,482,073 | 73,369 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,018,444 | 74,153 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,520,358 | 87,702 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,989,442 | 89,881 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,544,470 | 86,842 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $3,105,532 | 94,508 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $4,186,327 | 94,223 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,362,881 | 101,180 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,986,866 | 102,150 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,238,090 | 100,498 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,527,519 | 102,122 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,856,978 | 100,882 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,099,572 | 91,405 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,506,645 | 89,268 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,458,832 | 86,946 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,810,291 | 81,655 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,196,524 | 75,456 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,687,615 | 81,765 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,969,084 | 86,004 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,879,935 | 88,549 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,574,417 | 69,218 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,080,069 | 71,084 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,367,890 | 67,654 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,731,994 | 69,783 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,266,001 | 63,867 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||